RESUMEN
Vasoactive peptides like thrombin, angiotensin II and endothelin induce vascular smooth muscle cell (VSMC) contraction via activation of G-protein-coupled receptors. Recent studies have shown that they also induce VSMC migration and proliferation, processes which are important in the remodelling of the vasculature during embryogenesis and in the response to vascular injury. G-protein-coupled receptor-mediated mitogenic signals appear to be transmitted via a number of intracellular mechanisms which include proto-oncogene gene expression, G-protein-mediated protein translocation and tyrosine phosphorylation of growth factor receptor proteins, and activation of autocrine growth factor pathways. The ability of vasoactive peptides to have an impact on signalling cascades mediated by growth factor tyrosine kinase receptors may be important in the pathogenesis of diseases in the vasculature.
Asunto(s)
Proteínas de Unión al GTP/metabolismo , Músculo Liso Vascular/metabolismo , Receptores de Neuropéptido/metabolismo , Animales , División Celular/fisiología , Proteínas de Unión al GTP/fisiología , Humanos , Músculo Liso Vascular/citología , Proto-Oncogenes Mas , Receptores de Neuropéptido/fisiología , Transducción de Señal/fisiologíaRESUMEN
The guanine nucleotide analogue, 5'-p-fluorosulphonylbenzoyl guanosine (FSBG), can react covalently with GTP-binding proteins (G proteins). In rat brain membranes, FSBG causes a time-dependent loss of beta,gamma-imido[8-3H]guanosine 5'-triphosphate binding sites. Using 1 mM FSBG, the guanyl nucleotide modulation of opioid agonist binding is abolished, whereas the guanyl nucleotide sensitivity of neurotensin binding is retained. The action of FSBG can be prevented by the presence of opioid agonists, but not the antagonist naloxone. Iodoacetamide treatment of membranes in the presence of agonist, but not antagonist, can attenuate the action of FSBG in blocking guanyl nucleotide modulation of opioid agonist binding. These results suggest that FSBG covalently modifies essential thiol groups, whose exposure to the reagent is modified by agonist occupancy of the receptor, on a species of G protein linked to opioid receptors, but not on a species of G protein linked to neurotensin receptors. Thus, FSBG may have selectivity for the forms of Gi or Go, proteins associated with opioid receptors.
Asunto(s)
Marcadores de Afinidad/farmacología , Encéfalo/metabolismo , Proteínas de Unión al GTP/metabolismo , Guanosina/análogos & derivados , Receptores Opioides/metabolismo , Secuencia de Aminoácidos , Animales , Membrana Celular/metabolismo , Ditiotreitol/farmacología , Encefalina Ala(2)-MeFe(4)-Gli(5) , Encefalina Leucina/análogos & derivados , Encefalina Leucina/metabolismo , Encefalina Leucina/farmacología , Leucina Encefalina-2-Alanina , Encefalinas/farmacología , Guanosina/farmacología , Guanilil Imidodifosfato/metabolismo , Guanilil Imidodifosfato/farmacología , Yodoacetamida/farmacología , Cinética , Datos de Secuencia Molecular , Naloxona/farmacología , Ratas , Receptores Opioides/efectos de los fármacosRESUMEN
Cholecystokinin (CCK) binding sites were solubilized from pig cerebral cortical membranes with digitonin (2%, w/v) in the presence of Na+ (120 mM) and Mg2+ (5 mM). Scatchard plot transformation of equilibrium binding data obtained with 125I-CCK-8S gave an apparent dissociation constant (Kd) of 0.6 nM, comparable to that obtained in membranes in the presence of these cations. Hill coefficients close to unity suggested the presence of a single population of receptor sites. Competitive inhibition studies with pentagastrin, gastrin(1-17)S and the CCKA receptor antagonist L-364,718 indicated that the solubilized receptor sites were of the B-type (CCKB), with the same pharmacological profile as that observed in membranes. Optimal specific binding of 125I-CCK-8S to membrane-bound and solubilized receptors was obtained in the presence of divalent cations. Both the membrane-bound and the solubilized receptor activity were attenuated by guanylyl-imidodiphosphate (Gpp(NH)p) indicating that the brain CCKB receptors are coupled to G proteins.
Asunto(s)
Corteza Cerebral/metabolismo , Receptores de Colecistoquinina/aislamiento & purificación , Animales , Unión Competitiva/efectos de los fármacos , Cationes/farmacología , Corteza Cerebral/efectos de los fármacos , Colecistoquinina/metabolismo , Cromatografía Líquida de Alta Presión , Detergentes , Digitonina , Nucleótidos de Guanina/farmacología , Técnicas In Vitro , Radioisótopos de Yodo , Cinética , Membranas/efectos de los fármacos , Membranas/metabolismo , Receptores de Colecistoquinina/metabolismo , Albúmina Sérica Bovina/metabolismo , Porcinos , Termodinámica , Factores de TiempoRESUMEN
Opioid receptors solubilized in Mg2+-digitonin (2%, wt/vol) from Mg2+-pretreated rat brain membranes maintain, in addition to high-affinity opioid agonist binding, the modulation by guanine nucleotides. One of the modes of expression of the latter property is an attenuation of agonist binding by guanine nucleotides in the presence of Na+. To investigate the molecular basis of this modulation and to identify the G protein(s) involved, the soluble receptors were [32P]ADP-ribosylated by means of Bordetella pertussis toxin and subjected to molecular size exclusion chromatography. In addition, soluble extracts were chromatographed on lectin and hydrophobic affinity columns. The binding of 35S- and 3H-labelled analogues of GTP was also monitored in the species separated. The oligomeric G protein-coupled opioid receptors and the guanine nucleotide/pertussis toxin-sensitive species showed similar chromatographic properties in all three systems. This indicates that the biochemically functional G protein-opioid receptor complex formed in Mg2+-pretreated membranes in the absence of an agonist is stable in digitonin solution and to chromatographic separation. Further analysis showed that the guanine nucleotide modulation of opioid receptors is via the pertussis toxin substrates with Mr of 41,000 and 39,000, which are identified as Gi and Go alpha subunits, respectively.
Asunto(s)
Encéfalo/metabolismo , Proteínas de Unión al GTP/metabolismo , Toxina del Pertussis , Receptores Opioides/metabolismo , Factores de Virulencia de Bordetella/farmacología , Animales , Cromatografía/métodos , Cromatografía de Afinidad , Digitonina , Magnesio , Membranas/metabolismo , Ratas , Solubilidad , Aglutininas del Germen de TrigoRESUMEN
Pertussis toxin-catalyzed ADP-ribosylation of the guanine nucleotide-binding proteins Gi and Go is shown to proceed in Mg2+-digitonin extracts from rat brain; the Mr 41,000 and Mr 39,000 peptides are labelled there as in the membranes. The ADP-ribosylation in detergent solution retains the differential sensitivity to guanine nucleotide analogues. This reaction also removes the partial inhibition by the guanine nucleotides of the binding of opioid agonists, as does the same treatment in the membranes. The partial inhibition of agonist binding by Na+, however, is left unchanged. The binding of the antagonist naloxone is little affected by Na+ or by guanine nucleotides in the treated membranes, but the treated soluble receptors show an enhanced binding in high-Na+ medium, although still guanine nucleotide insensitive. The data suggest that the toxin reaction in the absence of guanine nucleotides and agonist stabilizes the opioid receptor in a receptor-G-protein coupled state which is no longer sensitive to guanine nucleotides but retains its sensitivity to the Na+ ions.
Asunto(s)
Adenosina Difosfato Ribosa/metabolismo , Encéfalo/metabolismo , Digitonina , Guanosina Trifosfato/farmacología , Toxina del Pertussis , Receptores Opioides/metabolismo , Factores de Virulencia de Bordetella/metabolismo , Animales , Membrana Celular/metabolismo , Electroforesis en Gel de Poliacrilamida , Encefalina Leucina/análogos & derivados , Encefalina Leucina/metabolismo , Leucina Encefalina-2-Alanina , Etorfina/metabolismo , Proteínas de Unión al GTP/metabolismo , Guanilil Imidodifosfato/farmacología , Cinética , Naloxona/metabolismo , Oligopéptidos/metabolismo , Ratas , Receptores Opioides/efectos de los fármacos , Sodio/farmacología , SolubilidadRESUMEN
Analysis of the equilibrium binding of [3H]-neurotensin(1-13) at 25 degrees C to its receptor sites in bovine cortex membranes indicated a single population of sites with an apparent equilibrium dissociation constant (KD) of 3.3 nM and a density (Bmax) of 350 fmol/mg protein (Hill coefficient nH = 0.97). Kinetic dissociation studies revealed the presence of a second class of sites comprising less than 10% of the total. KD values of 0.3 and 2.0 nM were obtained for the higher and lower affinity classes of sites, respectively, from association-dissociation kinetic studies. The binding of [3H]neurotensin was decreased by cations (monovalent and divalent) and by a nonhydrolysable guanine nucleotide analogue. Competition studies gave a potency ranking of [Gln4]neurotensin greater than neurotensin(8-13) greater than neurotensin(1-13). Smaller neurotensin analogues and neurotensin-like peptides were unable to compete with [3H]neurotensin. Stable binding activity for [3H]neurotensin in detergent solution (Kd = 5.5 nM, Bmax = 250 fmol/mg protein, nH = 1.0) was obtained in 2% digitonin/1 mM Mg2+ extracts of membranes which had been preincubated (25 degrees C, 1 h) with 1 mM Mg2+ prior to solubilization. Association-dissociation kinetic studies then revealed the presence of two classes of sites (KD1 = 0.5 nM, KD2 = 3.6 nM) in a similar proportion to that found in the membranes. The solubilized [3H]-neurotensin activity retained its sensitivity to cations and guanine nucleotide.
Asunto(s)
Corteza Cerebral/metabolismo , Neurotensina/metabolismo , Animales , Sitios de Unión , Unión Competitiva , Cationes/farmacología , Bovinos , Detergentes , Estabilidad de Medicamentos , Membranas/metabolismo , Neurotensina/análogos & derivados , Solubilidad , TritioRESUMEN
The neurotensin receptor protein, solubilized with digitonin/asolectin from bovine cerebral cortex membranes, was purified to apparent homogeneity by affinity chromatography using immobilized neurotensin. The product exhibits saturable and specific binding of [3,11-tyrosyl-3,5-3H]neurotensin with an apparent affinity (Kd = 5.5 nM) comparable to that measured in intact membranes and crude soluble extracts. The affinity-purified material, after reduction with 100 mM dithiothreitol, in denaturing gel electrophoresis showed a single polypeptide of Mr 72,000. Under nonreducing conditions the apparent Mr, however, was 50,000, suggesting the presence of intramolecular disulfide bonds. The purified neurotensin receptor was judged to be homogeneous, in that (i) only a single polypeptide was detectable; and (ii) the overall purification was 30,000-50,000-fold, giving a specific neurotensin-binding activity close to the theoretical maximum.
Asunto(s)
Encéfalo/metabolismo , Neurotensina/metabolismo , Receptores de Neurotransmisores/metabolismo , Animales , Bovinos , Cromatografía de Afinidad , Cinética , Peso Molecular , Receptores de Neurotensina , Receptores de Neurotransmisores/aislamiento & purificaciónRESUMEN
The binding isotherms of opioid receptors in rat brain membranes with [3H]D-Ala2-D-Leu5-enkephalin ([3H]DADLE), [3H]dihydromorphine ([3H]DHM), and [3H]etorphine were analysed to show the effects of Mg2+, Na+, and guanine nucleotides. Four opioid receptor subtypes of delta, kappa, mu 1, and mu 2 specificities were differentiated, where necessary with the aid of specific displacing ligands. Both a guanine nucleotide [guanosine-5'-(beta, gamma-imido)triphosphate] and the cations (Na+, Mg2+) affect the affinity state of all four subtypes of the receptor. The opioid binding behaviour is found on detailed inspection to be complex, with cases of "half-of-the-sites" reactivity and of cooperativity. By their behaviour under the various ionic conditions noted, it was concluded that these subtypes are distinct, without the need to assume interconvertibility by such agents. The evidence suggests that the formation of heterologous kappa-delta or mu 1-mu 2 receptor complexes is required for stabilization of the high-affinity conformational state of the receptor. Important effects of cations in increasing the binding and regulating the equilibria of receptor association-dissociation were observed when these studies were conducted, not in the Tris-HCl buffer commonly used in opioid binding assays, but in N-tris[hydroxymethyl]-methyl-2-aminoethanesulphonate (K+) buffer (TES-KOH; 10 mM, pH 7.5): it was found that ionic species of Tris can substitute for divalent cations. Dithiothreitol effects on agonist binding in the presence and absence of the cations suggested that those cation effects involve the exchange of -SH/-SS- bonds between receptor subunits. All of the behaviour is interpreted in terms of a model involving association-dissociation equilibria of homologous and/or heterologous receptor subunits of an oligomeric opioid receptor structure.
Asunto(s)
Encéfalo/metabolismo , Receptores Opioides/metabolismo , Sitio Alostérico , Animales , Cationes , Membrana Celular/metabolismo , Dihidromorfina/metabolismo , Encefalina Ala(2)-MeFe(4)-Gli(5) , Encefalina Leucina/análogos & derivados , Encefalina Leucina/metabolismo , Encefalina Leucina/farmacología , Leucina Encefalina-2-Alanina , Encefalinas/farmacología , Etorfina/metabolismo , Guanilil Imidodifosfato/farmacología , Cinética , Magnesio/farmacología , Masculino , Ratas , Ratas Endogámicas , Receptores Opioides/efectos de los fármacos , Sodio/farmacologíaRESUMEN
Stable opioid receptor binding activity that retains distinct subtype specificities (mu, delta, and kappa) has been obtained in high yields in digitonin extracts of rat brain membranes that had been preincubated with Mg2+ prior to solubilization. The dependence on Mg2+ ions for receptor activity is also expressed in the soluble state, where the presence of Mg2+ leads to high-affinity and high-capacity opioid peptide binding to the delta, mu, and kappa sites (the latter subtype measured by the binding of [3H]dynorphin1-8). Binding of opiate alkaloids to soluble receptor sites is less dependent on Mg2+ than is opioid peptide binding. Soluble opioid binding activity shows the same sensitivity to Na+ ions and guanine nucleotides as the membrane-bound receptor. The ligand-receptor interactions give evidence of strong positive cooperativity, which is interpreted in terms of association-dissociation of receptor subunits on ligand binding in solution. Binding of enkephalin peptides is associated with the large macromolecules present (apparent Stokes radii greater than 60 A), whereas both those and several small species present (less than 60 A) bind opiate alkaloids and dynorphin1-8.
Asunto(s)
Encéfalo/metabolismo , Receptores Opioides/metabolismo , Animales , Cationes , Membrana Celular/metabolismo , Fenómenos Químicos , Química Física , Cromatografía en Gel , Dihidromorfina/metabolismo , Dihidromorfina/farmacología , Dinorfinas/metabolismo , Encefalina Leucina/análogos & derivados , Encefalina Leucina/metabolismo , Leucina Encefalina-2-Alanina , Etorfina/metabolismo , Guanilil Imidodifosfato/farmacología , Yodoacetamida/farmacología , Cinética , Magnesio/farmacología , Naloxona/metabolismo , Ratas , Receptores Opioides/efectos de los fármacos , Sodio/farmacología , SolucionesRESUMEN
The binding sites for opiates (agonist and antagonist) and opioid peptides can be solubilized from rat brain membranes with digitonin in the presence of Mg2+ (10 mM). High affinity and high capacity binding to the soluble delta, mu, and kappa receptors is obtainable when the membranes are treated in Mg2+ (30 degrees C, 60 min) prior to solubilization. The yields of solubilized binding sites extracted with digitonin, 40-90%, are higher than those obtained from Mg2+-pretreated membranes with other detergents commonly used for receptor solubilization. The stability of the digitonin-soluble opioid receptor at room temperature makes it useful for purification and characterization.